Nephros (NEPH) Interest Coverage Ratio Growth (1y) (2013 - 2026)
Nephros (NEPH) Interest Coverage Ratio Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -60.91% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -75.56% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -74.28% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 155.18% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -99.91% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -117.38% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 114.19% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 123.74% |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | 153.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 153.30% |
| Sep 30, 2025 | -74.09% |
| Jun 30, 2025 | 114.45% |
| Mar 31, 2025 | 106.32% |
| Dec 31, 2024 | 160.02% |
| Sep 30, 2024 | 2,610.08% |
| Jun 30, 2024 | 51.61% |
| Mar 31, 2024 | -232.74% |
| Dec 31, 2023 | 101.55% |
| Sep 30, 2023 | 91.63% |
| Jun 30, 2023 | 54.83% |
| Mar 31, 2023 | 83.28% |
| Dec 31, 2022 | -124.27% |
| Sep 30, 2022 | 70.14% |
| Jun 30, 2022 | 79.47% |
| Mar 31, 2022 | 86.09% |
| Dec 31, 2021 | -86.23% |
| Sep 30, 2021 | 66.82% |
| Jun 30, 2021 | 44.08% |
| Mar 31, 2021 | -1,075.38% |